Until recently, the treatment of sarcoidosis was determined by empiric selection of drugs based on observational studies and expected drug toxicities. With improved understanding of the processes involved in granuloma formation, a framework for designing management strategies based on known pathogenic mechanisms in sarcoidosis is now possible to consider.
|Original language||English (US)|
|Title of host publication||Sarcoidosis|
|Number of pages||18|
|ISBN (Print)||0824759265, 9780824759261|
|State||Published - Jan 1 2005|
ASJC Scopus subject areas